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Abstract
I developed Graves’ Disease four months postpartum. After one year on propylthiouracil, I learned that omega-3
fatty acids may reduce inflammation associated with certain autoimmune disorders, although no investigations for
thyroiditis have been reported. Within eight weeks of beginning flaxseed oil supplements, TSH levels normalized,
but fell somewhat when flaxseed was decreased and PTU discontinued. During another pregnancy, plasma TSH
normalized, but was again suppressed by four weeks postpartum, then undetectable by four months. This time,
flaxseed supplementation alone coincided with TSH normalization. Omega-3 fatty acids should be investigated as a
potential treatment for autoimmune thyroid disease.
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Findings
I am a white female. In 2002 at age 38, I gave birth to
my fifth child. About four months later, I developed
heat intolerance, tremor, palpitations, increased fre-
quency of bowel movements, and elevated heart rate.
Plasma TSH was undetectable, and plasma T4 was ele-
vated at 2.41 ng/dL (reference range 0.65-1.50 ng/dL).
In addition, plasma thyrotropin binding inhibitory
immunoglobulin level was elevated at 21.4% (reference
range < 10%). Information on the lab results printout
stated, “This test measures the percent inhibition of
125I-TSH binding to the thyroid TSH receptor. Graves
Disease patients show an inhibition of 10-100%.” My
endocrinologist prescribed 10 mg methimazole twice
per day, but a rash developed, so I was switched to pro-
pylthioruacil (PTU), 150 mg twice per day. (Thyroid
ablation with radioactive iodine was not an option dur-
ing breastfeeding.) After about eight weeks when plasma
T4 levels came within normal range (1.1 ng/dL, refer-
ence range 0.7-1.9 ng/dL), I began to tapering off the
PTU without the physician’sc o n s e n t ,b u tT 4l e v e l s
began rising, and TSH remained undetectable. I
resumed taking PTU at 50-100 mg/day. At this dosage,
TSH was still undetectable, but T4 remained within
normal range, and I felt well. The endocrinologist would
have preferred that I take enough PTU to bring TSH up
to the normal range, but he continued to monitor me.
A thyroid uptake and scan were performed at about
six months after beginning PTU therapy. The 24-hour
uptake was elevated at 54.5 percent, and there was
homogeneous distribution of the iodine radioisotope
within a mildly enlarged gland, consistent with Graves’
disease.
Approximately one year into the PTU treatment, I
became aware that omega-3 fatty acids are thought to
reduce the inflammation associated with certain autoim-
mune disorders, such as rheumatoid arthritis [1]. They
have also been investigated with some success for such
conditions as Crohn’s disease, psoriasis, lupus erythema-
tosus, and multiple sclerosis [2]. N-3 fatty acids are
thought to exert their effects by suppressing the prolif-
eration of T lymphocytes and autoantibodies [3].
Further, animal studies have shown that consumption of
omega-3 alpha-linolenic acid leads to a change in the
fatty acid composition of immune cell membranes in a
dose dependent manner. As long-chain polyunsaturated
omega-3 fatty acids (LCPUFA) are incorporated into cell
membranes, less arachidonic acid is produced, and the
inflammatory response is thus inhibited [4-8].
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investigations of their use for autoimmune
hyperthyroidism.
With this information in mind, I began a regimen of
flaxseed oil supplements, 5-1,000 mg tablets twice a day.
Flaxseed oil is over 50% omega-3 fatty acids (mainly
alpha-linolenic acid), but it also contains about 15%
omega-6 fatty acids (mainly linoleic acid) [9]. Within
approximately eight weeks, TSH levels had normalized
for the first time (0.311 uIU/mL, reference range 0.300-
5.00 uIU/mL). PTU was then discontinued, and flaxseed
oil tapered to less than half the original dose, but TSH
levels slipped below normal again within six months
(0.29 uIU/mL, reference range 0.35-5.00 uIU/mL).
Symptoms were mild, and T4 was within normal range
(1.0 ng/dL, reference range 0.7-1.9 ng/dL), so I declined
to restart PTU therapy.
The following year, at about twenty weeks gestation
during a sixth pregnancy, plasma levels of TSH normal-
ized (0.726 uIU/mL, reference range 0.300-5.000 uIU/
mL). This was not unexpected, because gestational
increases in maternal plasma progesterone and estrogen
concentrations typically lead to a suppression of the
immune response, such as a shift in the population of T
lymphocytes from Th1 to Th2 autoimmune responses.
These changes lessen the probability of maternal rejec-
tion of the histoincompatible fetus and placenta. How-
ever, in the postpartum period, a shift back to a more
robust and sensitive immune response favors occurrence
or recurrence of postpartum thyroiditis [10,11]. Sure
enough, by the fourth week postpartum, my TSH was
again suppressed (0.174 uIU/mL, reference range 0.300-
5.000 uIU/mL), becoming undetectable by four months
postpartum. This time, however, plasma T4 remained
within normal range (1.7 ng/dL, reference range 0.7-1.9
ng/dL). Although the physician advised me to take a
low dose of PTU, I was experiencing no noticeable
symptoms of hyperthyroidism and declined the prescrip-
tion due to breastfeeding. As before, I then restarted a
flaxseed regimen at about six months postpartum (this
time, three tablespoons of whole seed on cereal each
morning). My condition began improving, and plasma
TSH normalized within six months (0.57 uIU/mL, refer-
ence range 0.35-5.00 uIU/mL). Flaxseed was then dis-
continued, and there has been no recurrence over the
following four plus years.
Admittedly, about one third of patients using antithyr-
oid agents can expect to experience a lasting remission
[11]. However, in the second case, my remission
occurred when I was not taking PTU, but not until
beginning flaxseed therapy. Further, even during the
first case, normalization of plasma TSH did not occur
during the first year of PTU therapy alone, but was
achieved within eight weeks of addition of a rich source
of omega-3 fatty acids, flax seeds, to the PTU therapy.
There is insufficient evidence to conclude that my
remission was caused by exposure to omega-3 fatty
acids. However, the seemingly unlikely coincidences sug-
gest a possible cause and effect relationship. The critical
point is that a clinical trial of omega-3 fatty acid supple-
ments for postpartum thyroiditis or Graves’ disease
seems warranted. Such a trial could be done while con-
tinuing other therapies such as methimazole or PTU,
and would involve minimal risk at minimal expense.
Clinical studies would be well advised to establish a
secure dose of daily intake of omega-3 fatty acids, as
well as the relative proportions of omega-3 and omega-6
fatty acids. Low doses of antioxidants, such as vitamin E
or certain flavonoids, might also be added, because they
may protect the body against the oxidative stress that
omega-3 fatty acids can cause [12].
If a safe, easy, and cost effective new treatment could
be found that increases a patient’s odds of complete
remission of Graves’ disease, more people would be
spared ablation therapy and lifelong thyroxine
supplementation.
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